It is currently Tue May 24, 2016 3:08 am

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.

BRITISH RESEARCHERS MAY HAVE JUST FOUND THE CURE FOR M.S

HI friends good news from british researchers please read
http://dailyrecords.us/british-research ... sclerosis/
regards
seeva
Read more : BRITISH RESEARCHERS MAY HAVE JUST FOUND THE CURE FOR M.S | Views : 157 | Replies : 0


PLANT EXTRACT EFFECTIVE AGAINST M.S PROGRSSION IN ANIMAL MOD

HI Friends new plant extract drug called T20K soon in the market please read more
http://www.hcplive.com/medical-news/pla ... mal-models
regards
seeva
Read more : PLANT EXTRACT EFFECTIVE AGAINST M.S PROGRSSION IN ANIMAL MOD | Views : 314 | Replies : 3


Oral antioxidant - lipoic acid

Hi all,

Thought this may be worth posting on this board as well. We recently conducted an interview with Dr Rebecca Spain, who has just finished a small clinical trial looking at using the oral antioxidant, lipoic acid, as a treatment in people with secondary progressive MS.

You can view the interview here:

https://www.youtube.com/watch?v=JTGVHQt66YA

Or if you would prefer to read the written transcript, that's also available on our ...
Read more : Oral antioxidant - lipoic acid | Views : 425 | Replies : 2


Over the counter antihistamine may stimulate myelin repair

A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially reverse damage to the optic nerve in people with multiple sclerosis (MS). This release comes ahead of the researchers from the University of California, San Francisco presenting their data at the annual American Academy of Neurology meeting being held in Vancouver, Canada between April 15-21.

This study arose from earlier work by ...
Read more : Over the counter antihistamine may stimulate myelin repair | Views : 538 | Replies : 4


Redhill announces Phase IIa trial data

RedHill Biopharma has announced “encouraging” top-line interim results from its CEASE-MS Phase IIa proof-of-concept (PoC) clinical study evaluating fixed oral doses of RHB-104 in patients treated for relapsing-remitting multiple sclerosis (RRMS)....Read more - http://www.ms-uk.org/MSnews
Read more : Redhill announces Phase IIa trial data | Views : 491 | Replies : 3




baclofen

Does anyone take a low dose of baclofen? I wake up and I'm stiff as a board.
Read more : baclofen | Views : 411 | Replies : 5




The Latest Innovations in the Drug Pipeline for MS

A review of investigational drugs in ongoing Phase 3 studies:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684635/
Read more : The Latest Innovations in the Drug Pipeline for MS | Views : 751 | Replies : 0


Potential new therapeutic for Relapsing MS patients

RADIANCE phase 2 trial of ozanimod, an investigational selective S1P 1 and 5 receptor modulators for relapsing multiple sclerosis (MS) patients results showed significant reductions in the cumulative number of total gadolinium-enhancing (GdE) lesions...Read more - http://www.ms-uk.org/MSnews
Read more : Potential new therapeutic for Relapsing MS patients | Views : 752 | Replies : 0


 

Login  •  Register


Statistics

Total posts 232432 • Total topics 24846 • Total members 16004


Contact us | Terms of Service